Compare RCUS & SKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RCUS | SKE |
|---|---|---|
| Founded | 2015 | 1979 |
| Country | United States | Canada |
| Employees | 601 | 170 |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.3B |
| IPO Year | 2018 | 2017 |
| Metric | RCUS | SKE |
|---|---|---|
| Price | $28.53 | $27.12 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $31.90 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 661.1K |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $247,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $45.62 | $37,573.35 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.84 | $13.81 |
| 52 Week High | $31.74 | $38.77 |
| Indicator | RCUS | SKE |
|---|---|---|
| Relative Strength Index (RSI) | 51.38 | 49.74 |
| Support Level | $20.20 | $24.86 |
| Resistance Level | $28.72 | $34.86 |
| Average True Range (ATR) | 1.33 | 1.33 |
| MACD | -0.16 | 0.16 |
| Stochastic Oscillator | 50.83 | 61.37 |
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.
Skeena Resources Ltd is a mining company in development stage focusing on the construction and development of the Eskay Creek project in British Columbia. Eskay Creek is the next global gold development project and represents one of the highest-grade and lowest-cost open-pit precious metals mines, with substantial silver by-product production.